
The massive life sciences meeting now known as the J.P. Morgan Healthcare Conference started out as a clubby get-together hosted by investment bank Hambrecht & Quist.
Back in the days of H&Q, bankers and entrepreneurs flocked to San Francisco to get information about biotech companies that was otherwise hard to come by. Investors, thrilled-or spooked-by the details proffered by company representatives, would rush to a trading desk set up in the Westin St. Francis Hotel, says long-time conference attendee Joe Panetta, president and CEO of California’s Biocom, who returned this year for the 37th annual. (Read Xconomy’s annual reporter’s notebook-style JPM… Read more »
UNDERWRITERS AND PARTNERS